Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ANTXR2 | P58335 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 7/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | ELANE | P08246 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | NQO1 | P15559 | 1/20 | 0.44 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7964266 | 0.77 | ANTXR2 (0.47) | MAPTCYP3A4ANTXR2TP53MAOA | |
| SCHEMBL11790033 | 0.77 | ANTXR2 (0.47) | MAPTCYP3A4ANTXR2MAOAMEN1 | |
| SCHEMBL28016321 | 0.77 | ANTXR2 (0.47) | MAPTCYP3A4ANTXR2TP53MAOA | |
| SCHEMBL9149137 | 0.77 | MEN1 (0.48) | MAPTCYP3A4ANTXR2MAOAMEN1 | |
| SCHEMBL16432832 | 0.76 | KDM4E (0.41) | MAPTCYP3A4ANTXR2TP53MAOA | |
| SCHEMBL11791101 | 0.76 | ANTXR2 (0.46) | MAPTCYP3A4ANTXR2TP53MAOA | |
| SCHEMBL8507929 | 0.75 | NQO1 (0.48) | MAPTCYP3A4ANTXR2TP53MAOA | |
| SCHEMBL1308058 | 0.74 | KMT2A (0.59) | MAPTCYP3A4MEN1KMT2AKDM4E | |
| SCHEMBL9461565 | 0.74 | KMT2A (0.51) | MAPTCYP3A4ANTXR2MEN1KMT2A | |
| SCHEMBL800045 | 0.74 | MAPT (0.54) | MAPTCYP3A4ANTXR2MAOAMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260008702-A1 | CATALYST FOR DECOMPOSING ORGANIC MATTER AND SYSTEM FOR DECOMPOSING ORGANIC MATTER COMPRISING THE SAME | UNIV INDUSTRY COOPERATION GROUP KYUNG HEE UNIV (KR) | 2026-01-08 | — | — | US | disclosed |
| US-11897793-B2 | Catalysts for Fenton system containing metal oxide containing functional group on surface and Fenton system using the same | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2024-02-13 | — | — | US | disclosed |
| CN-113441125-B | Catalyst for Fenton reaction system comprising metal oxide having functional group on surface and Fenton reaction system using same | 韩国科学技术研究院 | 2023-11-24 | — | — | CN | disclosed |
| CN-112795617-B | Marine fungus secondary metabolite and preparation and application thereof | 海南大学 | 2023-07-07 | — | — | CN | disclosed |
| US-20220127255-A1 | HERBICIDAL COMPOUNDS | SYNGENTA CROP PROTECTION AG (GB) | 2022-04-28 | — | — | US | disclosed |
| CN-112795617-A | Marine fungus secondary metabolite and preparation and application thereof | 海南大学 | 2021-05-14 | — | — | CN | disclosed |
| US-20170157111-A1 | HIF INHIBITORS AND USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2017-06-08 | — | — | US | disclosed |
| US-9604958-B2 | HIF inhibitors and use thereof | THE GENERAL HOSPITAL CORPORATION (US) | 2017-03-28 | — | — | US | disclosed |
| US-20150023868-A1 | HIF INHIBITORS AND USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2015-01-22 | — | — | US | disclosed |
| EP-2429993-B1 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | BOEHRINGER INGELHEIM INT (DE) | 2015-01-21 | — | — | EP | disclosed |
| US-20120070369-A1 | HIF INHIBITORS AND USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2012-03-22 | — | — | US | disclosed |
| WO-2010068794-A2 | HIF INHIBITORS AND USE THEREOF | THE GENERAL HOSPITAL CORPORATION (US) | 2010-06-17 | — | — | WO | disclosed |
| US-20070111952-A1 | Glycosylated triketide delta lactones | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220127255-A1 | HERBICIDAL COMPOUNDS | DDT, HDHD5, HPD | MAPT 3573/4885CYP3A4 672/4885ANTXR2 2417/4885 |
| US-20120070369-A1 | HIF INHIBITORS AND USE THEREOF | HIF1AN, HIF1A, EGLN3 | MAPT 4004/4885CYP3A4 4195/4885ANTXR2 1573/4885 |
| US-20070111952-A1 | Glycosylated triketide delta lactones | AGL, AKR1C3, AKR1C4 | MAPT 4801/4885CYP3A4 305/4885ANTXR2 638/4885 |
| US-20260008702-A1 | CATALYST FOR DECOMPOSING ORGANIC MATTER AND SYSTEM FOR DECOMPOSING ORGANIC MATTER COMPRISING THE SAME | HAO2, AOC3, OR10J3 | MAPT 2440/4885CYP3A4 44/4885ANTXR2 2772/4885 |
| US-20150023868-A1 | HIF INHIBITORS AND USE THEREOF | HIF1AN, HIF1A, EGLN3 | MAPT 4004/4885CYP3A4 4195/4885ANTXR2 1573/4885 |
| US-20170157111-A1 | HIF INHIBITORS AND USE THEREOF | HIF1AN, HIF1A, EGLN3 | MAPT 4004/4885CYP3A4 4195/4885ANTXR2 1573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.